Hyderabad, July 10, 2007
Glimy MPTM (Glimepiride+ Metformin+ Pioglitazone) was launched nationwide last month, marking the entry of Dr Reddy’s in the triple drug combination oral hypoglycemic agents market. Glimy MPTM is an extension of the existing products of Dr Reddy’s used in the management of Type 2 diabetes. It is a one-step approach to intensive glycemic control.
Glimy MPTM is available in dosages of 1mg (Glimy MP1) and 2mg (Glimy MP2), in sizes of 10tabs / strip and 10strips/pack. The triple drug combination offers the range of options available for the doctor to address their needs in different situations in the management of type 2 diabetes.
|
